EMAIL THIS PAGE TO A FRIEND

Oncology reports

Restoration of fibroblast growth factor receptor 2IIIb enhances the chemosensitivity of human prostate cancer cells.


PMID 24839986

Abstract

Fibroblast growth factor receptor 2 (FGFR2) is thought to mediate an important signaling pathway between prostate epithelial cells and stromal cells for maintenance of homeostasis in normal prostate tissue. Abnormalities of FGFR2 have been shown in advanced prostate cancer or prostate cancer cell lines, and we previously demonstrated the tumor-suppressive effects of the restoration of FGFR2IIIb in prostate cancer cells. The aim of the present study was to determine whether FGFR2IIIb plays a role in the chemosensitivity of castration-resistant prostate cancer cells. A clonal line of PC-3 cells expressing FGFR2IIIb (PC-3R2IIIb) was established by transfection with an IRESneo2-expressing vector bearing FGFR2IIIb cDNA. The effects of chemotherapeutic agents (docetaxel, cisplatin, 5-fluorouracil and zoledronic acid) on cell viability and apoptosis were examined by MTT assay and western blot analysis, respectively. Expression levels of molecules that were markers of epithelial-to-mesenchymal transition and chemosensitivity-related proteins were assessed by western blot analysis. Viability of the PC-3R2IIIb cells was significantly lower than that of the control PC-3 cells transfected with the vector alone (PC-3neo), and viability was further suppressed by treatment with chemotherapeutic agents, particularly docetaxel. Induced expression of caspase-3 was evident in the PC-3R2IIIb cells and was further enhanced by treatment with docetaxel. Expression of N-cadherin, vimentin, survivin and XIAP was lower in the PC-3R2IIIb cells than that in the PC-3neo cells. In contrast, expression of p21 was higher in the PC-3R2IIIb cells than that in the control PC-3neo cells. These data indicate that restoration of FGFR2IIIb in castration-resistant prostate cancer cells may reverse some of the epithelial-to-mesenchymal cell properties characteristic of tumor cells and induce in part mesenchymal-to-epithelial transition properties. This together with enhancement of apoptotic pathways involving caspase-3 may enhance chemosensitivity particularly to docetaxel which is widely used in the treatment of castration-resistant prostate cancer.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA002199
Anti-ABCB1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2702025
Anti-ABCB1 antibody produced in rabbit
SAB1411890
ANTI-BIRC4 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
HPA002830
Anti-BIRC5 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2701861
Anti-cdh1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA004812
Anti-CDH1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2104222
Anti-CDH1 antibody produced in rabbit, affinity isolated antibody
SAB4300693
Anti-CDH1 antibody produced in rabbit, affinity isolated antibody
SAB2107370
Anti-CDH1 antibody produced in rabbit, affinity isolated antibody
SAB4300621
Anti-CDH2 antibody produced in rabbit, affinity isolated antibody
HPA000572
Anti-CLU antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB3500199
Anti-Clusterin antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1400065
Anti-CYP3A4 antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB2101297
Anti-KRAS antibody produced in rabbit, affinity isolated antibody
HPA049830
Anti-KRAS antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2107115
Anti-KRAS antibody produced in rabbit, affinity isolated antibody
SAB2700181
Anti-NS3 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4501190
Anti-NSG1 antibody produced in rabbit, affinity isolated antibody
P7874 Anti-p53 antibody, Mouse monoclonal, clone DO-2, purified from hybridoma cell culture
P6874
Anti-p53 antibody, Mouse monoclonal, clone DO-1, purified from hybridoma cell culture
S8191
Anti-Survivin antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB4501460
Anti-Survivin antibody produced in rabbit, affinity isolated antibody
HPA000262
Anti-TBC1D9 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA006503
Anti-TBC1D9 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4503030
Anti-TCTP antibody produced in rabbit, affinity isolated antibody
SAB1406544
Anti-TP53 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1406585
Anti-VIM antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
PRS3331
Anti-XIAP antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
EHU111621 MISSION® esiRNA, esiRNA human TPT1 (esiRNA1)
EHU114431
MISSION® esiRNA, esiRNA human KRAS (esiRNA1)